Ethicon Endo-surgery, Inc.

Other

Devicor Medical Products, Inc.

Thomas Edward Albrecht

Mark S Zeiner

Jason L Harris

Mark S Ortiz

Michael J Stokes

Frederick E Shelton, IV

Christopher J Hess

John A Hibner

James Walden Voegele

Andrew M Zwolinski

Mark D Overmyer

Michael S Cropper

Tamara S Vetro Widenhouse

William Bruce Weisenburgh, Ii

Jeffrey L Aldridge

Sean P Conlon

Galen C Robertson

Prasanna Malaviya

Daniel F Dlugos, Jr

James A Woodard, Jr

Alessandro Pastorelli

Elizabeth Sebern

Denzel Z Herrera-Davis

Nitin Kumar Jain

Tina Denise Hunter

Diane M Francis

David C Yates

Foster B Stulen

James R Giordano

John V Hunt

Lawrence Crainich

Christopher W Widenhouse

Lauren S Weaner

Matthew D Holcomb

David Denis Beck

Kevin L Houser

Jeffrey David Messerly

Richard L Leimbach

Andrew T Beckman

Thomas W Huitema

Richard F Schwemberger

David Keith Norvell

Kevin D Felder

Michael A Murray

Tamara Colette Baynham

David James Cagle

Randal T Byrum

Daniel L Baber

Amy L Marcotte

Michele D'Arcangelo

Lee E Reichel

Thomas A Gilker

Anthony R DiUbaldi

Kristin L Jambor

Jon D Buzzard

Anthony T Nguyen

Eduardo Salazar

Daniel E Alesi

Gwendolyn Ruth Perez

Mario Gutierrez

Jacob Crabtree

Glenda C Marsh

Kristen L Jambor

Mark S Oritz

Various systems and methods for predicting metabolic and bariatric surgery outcomes are provided. The systems and methods can also provide predictions for non-surgical metabolic and bariatric treatments. In general, a user can receive predictive outcomes of multiple bariatric procedures that could be performed on a patient. In one embodiment, a user can electronically access a metabolic and bariatric surgery outcome prediction system, e.g., using one or more web pages. The system can provide predictive outcomes of one or more different bariatric surgeries for the patient based on data gathered from the user and on historical data regarding outcomes of the different bariatric surgeries. The system can additionally provide predictive outcomes for not having any treatment and/or a comparison of the predictive outcomes of the one or more different bariatric surgeries to the predictive outcomes for not having any treatment.

Systems and methods for predicting metabolic and bariatric surgery outcomes

Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems, and ingestible pills. In one embodiment, the implantable system comprises a device delivering a therapeutic substance to a target location within the gastrointestinal tract of a patient in order to initiate an intestinal braking effect which would promote sensations of satiety and stimulate excess weight loss for the patient.

Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods

An endoluminal sleeve device for internally lining a section of the GI tract, comprises a sleeve configured for deployment inside a duodenum, the sleeve having walls of a flexible material defining a sleeve lumen, a proximal end defining a proximal lumen opening, and a distal end defining a distal lumen opening, an anchoring component having a slender transport configuration and a bulky deployed configuration, wherein the anchoring component is locatable at a distance from the proximal sleeve end and connected thereto by an elongated tether.

Devices and methods for anchoring an endoluminal sleeve in the GI tract

In various forms, a sensor-straightened end effector is disclosed. The sensor-straightened end effector may comprise an end effector coupled to a shaft at an articulation point. The end effector may be articulable at an angle with respect to the shaft. A sensor may be disposed on the sensor-straightened end effector, such as on the shaft or on the end effector. The sensor is configured to detect a gross proximal movement. When detecting a gross proximal movement, the sensor may generate a signal to control a motor to begin a straightening process to straighten the end effector with respect to the shaft.

Sensor straightened end effector during removal through trocar

Methods and devices create an intestinal braking effect, are non-invasive or minimally invasive, and may be reversible. These methods and devices are accomplished via stabilized implantable systems and ingestible pills. In one embodiment, a method of producing satiety comprising the steps of accessing a gastrointestinal tract of a patient and implanting an intraintestinal therapeutic substance eluting implant. The implant is capable of eluting a satiety inducing substance selected from at least one of a nutrient, a specific satiety inducing bio-active substance, pancreatic polypeptides, free fatty acids, cholecystokinin, amino acids, glutamine, lipids, linoleic acid, or a combination thereof, from the implant into the gastrointestinal tract.

Self-positioning of at least a portion of a transdermal electrical stimulation patch within a target area (e.g., supraclavicular fossa region) of a human body to activate a depot of brown adipose tissue therein. An electric field is generated using the electrical stimulation patch to activate the brown adipose tissue within the supraclavicular fossa region of the body. The patch is self-positioned using one or more anatomical points (e.g., anatomical landmarks and/or anatomical features) or markings on the body. Brown adipose tissue may also be activated by applying an electrical signal to a body piercing partially implanted proximate a target area in which the tissue is disposed.

Device and method for self-positioning of a stimulation device to activate brown adipose tissue depot in a supraclavicular fossa region

A biopsy device comprises a probe assembly and an obturator. The probe assembly comprises a cannula having a closed distal end configured to penetrate tissue, an open proximal end, a first lumen in fluid communication with the open proximal end, and a side aperture located proximal to the closed distal end. The side aperture is in fluid communication with the first lumen. The obturator is removably insertable in the first lumen through the open proximal end. The obturator is configured to substantially block the side aperture when the obturator is inserted in the first lumen. The probe assembly may be inserted in a patient's tissue (e.g., breast) with the obturator disposed in the cannula to block the side aperture. The obturator may then be removed, and a cutter may be advanced through the cannula to sever tissue protruding through the side aperture.

MRI compatible biopsy device with detachable probe

An endoscopic apparatus shaped and dimensioned for passage through an orifice in the body includes a scope attachment member coupled to an endoscopic instrument, and a connection member attaching the scope attachment member to the endoscopic instrument. The connection member has an insertion orientation sized for passage through the orifice and a deployed orientation too large to pass though the orifice. When the connection member is in its insertion orientation the endoscopic instrument is positioned closely adjacent an exterior of an endoscope for low profile insertion of the endoscopic instrument through an orifice, and when the connection is in its deployed orientation the endoscopic instrument is spaced from the endoscope to improve visibility.

Attachment apparatus for coupling with an endoscope

Methods and devices reroute chyme to induce intestinal brake in order to improve the effectiveness of bariatric surgical procedures and to improve comorbidity resolution. A bowel is manipulated to provide a shortened path for chyme to travel to the ileum. These methods and devices of rerouting chyme to induce intestinal brake may include one or more of a surgical procedure, an implanted device, or a combination of an implant with an improved surgical procedure.

Methods and devices for the rerouting of chyme to induce intestinal brake

A method for treating obesity by reducing the volume and/or alter the functioning of the gastric cavity to limit food consumption and induce early satiety. The method includes accessing the cavity endoscopically to visualize the interior of the cavity. The peritoneal cavity is accessed through a small incision in the abdominal wall. Using endoscopic visualization, suture anchoring devices are introduced into the peritoneal cavity through the incision and deployed from the exterior surface through the gastric cavity wall. Suture from pairs of the anchoring devices is drawn through the gastric cavity wall and tightened outside of the cavity to form a serosa to serosa plication. Any number of plications may be formed in the cavity wall and the contacting tissue within a plication may be treated to promote healing and a more durable bond.

Hybrid endoscopic/laparoscopic method for forming serosa to serosa plications in a gastric cavity

Various exemplary methods and devices are provided for tensioning suture. The methods and devices are particularly useful in surgical suturing applications in which it is desirable to maintain tension on suture being delivered, yet to allow the tension to be released as desired without retracting the suture. Thus, when tension is released, a length of suture extended from the device can remain extended without any tension being applied thereto. Tension is only applied to any additional length of suture that is extended from the device. The tension applied to the suture is proportional to the length of the suture extended from the device until the tension is released and reset.

Suture management

An inflatable medical instrument for tissue damage in gastric reduction surgery includes a main chamber composed of a biocompatible material capable of being selectively inflated. The medical instrument also includes a longitudinally extending tab member secured to an outer surface of the main chamber, a series of suction holes are formed along the tab member and an electrode is mounted on the tab member. The present invention also provides a method for forming a tissue junction used in defining a gastric pouch including damaging opposed tissue layers, apposing the tissue layers and fastening the tissue layers to allow the tissue layers to heal together.

Balloon tissue damage device

Growing community of inventors

Cincinnati, OH, United States of America

Thomas Edward Albrecht